Professor Lawrence Stanberry

Image of Professor Lawrence Stanberry Dr Lawrence Stanberry is the Reuben S Carpentier Professor and Chairman of the Department of Pediatrics at the College of Physicians and Surgeons at Columbia University, and Pediatrician-in-Chief of the Morgan Stanley Children’s Hospital of New York Presbyterian. Dr Stanberry received a BS in Chemistry from Southwestern University in Georgetown, Texas and MD (James Scholar) and PhD (Pharmacology) degrees from the University of Illinois in Chicago. His postgraduate medical training was in Pediatrics, Infectious Diseases and Virology at the University of Texas Southwestern Medical School in Dallas and the University of Utah in Salt Lake City. From 2000 to 2008, he was the John Sealy Distinguished Professor and Chairman of Pediatrics and Director of the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston. Prior to joining the faculty in Galveston, he was the Albert B Sabin Professor of Pediatrics and Director of the Division of Infectious Diseases at the Cincinnati Children’s Medical Center and University of Cincinnati College of Medicine. Dr Stanberry is an internationally recognized authority on vaccine development and viral diseases.

He has served on numerous advisory and review panels including serving as the chair of the Vaccine Study Section and the Pediatrics Review Panel at the National Institutes of Health. He has received research funding from the National Institutes of Health, the Centers for Disease Control and Prevention, numerous vaccine, pharmaceutical and biotech companies, and the Bill and Melinda Gates Foundation. His areas of research include the development of antiviral drugs, topical microbicides and prophylactic and therapeutic vaccines, basic studies of the pathogenesis and immunobiology of herpes simplex virus, and the special problems of neonatal herpes and genital herpes infection in teenagers. His laboratory provided the first experimental evidence to support the concept of vaccine immunotherapy for the treatment of persistent viral infections. Dr Stanberry was one of the lead researchers on the GlaxoSmithKline herpes simplex virus vaccine trials. These trials produced the first scientific evidence that a vaccine could protect humans against genital herpes infection. An unexpected finding of these trials was that the vaccine was effective only in women. This was the first demonstration of gender-specific vaccine protection.

Dr Stanberry has authored over 175 scientific articles and is the editor of the textbook, “Genital and Neonatal Herpes” published by John Wiley and Sons, Ltd, London (1996), the co-editor (with Dr David Bernstein) of the textbook, “Sexually Transmitted Diseases: Vaccines, Prevention, and Control” published by Academic Press, Ltd, London (2000), the co-editor (with Dr Alan Barrett) of a new textbook entitled, “Vaccines for Biodefense and Emerging and Neglected Diseases” published by Elsevier (London) in 2009. He is also the author of a book for the general public entitled, “Understanding Herpes” published by the University Press of Mississippi, Jackson, Mississippi (2nd edition 2006).